Literature DB >> 22403056

Elucidating disparities across racial and ethnic groups in multiple myeloma patients.

Alexandra J Greenberg, S Vincent Rajkumar.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22403056     DOI： 10.1007/s12185-012-1040-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients.

Authors:  Hakan Kaya; Benjamin Peressini; Irfan Jawed; Danko Martincic; Ameer L Elaimy; Wayne T Lamoreaux; Robert K Fairbanks; Kevin A Weeks; Christopher M Lee
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

Review 2.  Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis.

Authors:  O Landgren; B M Weiss
Journal:  Leukemia       Date:  2009-07-09       Impact factor: 11.528

3.  Cancer-related disparities and opportunities for intervention in Northern Plains American Indian communities.

Authors:  Shinobu Watanabe-Galloway; Nicole Flom; Liyan Xu; Tinka Duran; Leah Frerichs; Favian Kennedy; Corey B Smith; Adeola O Jaiyeola
Journal:  Public Health Rep       Date:  2011 May-Jun       Impact factor: 2.792

4.  Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.

Authors:  Brendan M Weiss; Alex Minter; Jude Abadie; Robin Howard; Joao Ascencao; Geraldine P Schechter; Michael Kuehl; Ola Landgren
Journal:  Am J Hematol       Date:  2011-05-04       Impact factor: 10.047

5.  A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly.

Authors:  M Bowden; J Crawford; H J Cohen; O Noyama
Journal:  J Am Geriatr Soc       Date:  1993-01       Impact factor: 5.562

Review 6.  Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.

Authors:  A J Greenberg; C M Vachon; S V Rajkumar
Journal:  Leukemia       Date:  2011-12-23       Impact factor: 11.528

7.  Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.

Authors:  Youlian Liao; David Bang; Shannon Cosgrove; Rick Dulin; Zachery Harris; April Taylor; Shannon White; Graydon Yatabe; Leandris Liburd; Wayne Giles
Journal:  MMWR Surveill Summ       Date:  2011-05-20

8.  Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.

Authors:  S Vincent Rajkumar; Susanna Jacobus; Natalie S Callander; Rafael Fonseca; David H Vesole; Michael E Williams; Rafat Abonour; David S Siegel; Michael Katz; Philip R Greipp
Journal:  Lancet Oncol       Date:  2009-10-21       Impact factor: 41.316

9.  Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.

Authors:  Masako Iwanaga; Masuko Tagawa; Kunihiro Tsukasaki; Shimera Kamihira; Masao Tomonaga
Journal:  Mayo Clin Proc       Date:  2007-12       Impact factor: 7.616
  9 in total
  1 in total

1.  Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.

Authors:  Dickran Kazandjian; Elizabeth Hill; Malin Hultcrantz; Evan H Rustad; Venkata Yellapantula; Theresia Akhlaghi; Neha Korde; Sham Mailankody; Alex Dew; Elli Papaemmanuil; Irina Maric; Mary Kwok; Ola Landgren
Journal:  Blood Cancer J       Date:  2019-02-04       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.